Drugs / Norbuprenorphine
last change Jun 2016 re-read 2 minutes ago

Norbuprenorphine

Small molecule

Investigated by
GlaxoSmithKline · ViiV Healthcare

Trials 1 · a red edge is where a trial was stopped

20162017201820192020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT02666001 Jan → Jun 2016 HIV infectious disease ViiV Healthcare Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as Norbuprenorphine ClinicalTrials.gov intervention name — accepted as the source's own label NCT02666001
Modality Small molecule CHEMBL1743323